Shalby Ltd.

168.68

3.9 (2.4%)growUp

SHALBY Share Price
As on January 28, 2026
SectorHealthcare
IndustryHEALTHCARE SERVICES
Basic IndustryHOSPITAL
Market Cap1,834 Cr
P/E Ratio291.38
Dividend YieldN/A
Trendline Performance

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open167.19
High170.9
NSE SymbolSHALBY
Close168.68
Low165.62
BSE Symbol540797
Previous Years High/Low
1 Year High274.7
3 Year High339.5
5 Year High339.5
1 Year Low160.4
3 Year Low115
5 Year Low94.95

Technicals


IndicatorsValueSignal
5-DMA167.9Bullish
10-DMA172.96Bearish
20-DMA183.84Bearish
50-DMA195.76Bearish
100-DMA218.8Bearish
200-DMA205.77Bearish

Historical Performance


1 Year
-19.4%
3 Years
18%
5 Years
53.8%
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


ParticularsMar-2025Mar-2024Mar-2023Mar-2022Mar-2021
Other Income27619422512491
Operating Profit1,6231,9801,6071,340964
Interest4081761067545
Depreciation658522481429368
Profit Before Tax5571,2821,020791551
Consolidated Net Profit62841677541424
Adjusted EPS18654
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


ParticularsMar-2025Mar-2024Mar-2023Mar-2022Mar-2021
Share Capital1,0751,0741,0731,0801,080
Total Reserves8,8368,9218,1967,6837,266
Long-Term Borrowings---------------
Total Non-Current Liabilities2,8953,8782,6952,3361,500
Other Current Liabilities927865559571236
Short Term Borrowings2,4071,040491435---
Total Liabilities17,40217,18913,91512,82210,665
Capital Work in Progress80106624540
Long Term Loans & Advances9141,8001,7591,4821,206
Currents Investments9468061,457247155
Short Term Loans and Advances261553620703367
Total Current Assets6,5805,5225,1734,4232,711
Total Assets17,40217,18913,91512,82210,665
Adjusted Book Value9293868177
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 291.38, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a moderate 3-year price CAGR of 5.0%, reflecting average market performance.
  • The stock carries a beta of 1.0, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹1623 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹10870 million, indicating a large and established business.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 788998.5
No. of Shares: 4677 (Approx)
Performance:-21.1%
P/L: ₹-211001.5
NIFTY Performance: 9.4%
1 day Top Gainers
SymbolChange%
TEJASNET339.05(15%)
DATAPATTNS2610.6(14%)
HINDCOPPER633.4(13%)
OLECTRA1088.4(10%)
SCHNEIDER697.7(10%)
1 Day Top Losers
SymbolChange%
RADICO2746.8(-6%)
HOMEFIRST1190.9(-5%)
TATACONSUM1131.8(-5%)
ASIANPAINT2511.8(-4%)
VMM119.86(-4%)
BERGEPAINT478.85(-3%)
EMCURE1435.8(-3%)
AIIL502.1(-3%)

Top Performing Stocks from the same sector


Lotus Eye Hospital And Institute Ltd.

5.1%

134.65

1 Month Performance

Take Solutions Ltd.

0.9%

38.45

1 Month Performance

Sastasundar Ventures Ltd.

0%

301.15

1 Month Performance

Dr. Lal Pathlabs Ltd.

-0.3%

1400.4

1 Month Performance

Thyrocare Technologies Ltd.

-0.4%

458.7

1 Month Performance

Krsnaa Diagnostics Ltd.

-2%

716.75

1 Month Performance

Krishna Institute of Medical Sciences Ltd

-2.7%

609.65

1 Month Performance

Suraksha Diagnostic Ltd.

-2.8%

263.3

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month